While large language models have been around for a while, OpenAI's ChatGPT has sparked unprecedented interest in their application in diverse domains, including problems in drug discovery.
In these early days, ChatGPT and similar models are showing promising signs:
Written in collab with Fierce Biotech, the whitepaper discusses the potential and possibilities the model can bring to make drug research a less laborious process. Here we demystify it’s underlying technology, hypothesize on it’s applications in various steps of discovery and discuss limitations.
Get the latest news, industry insights, and updates delivered directly to your inbox.